Hospital Universitario Araba
- Address
- lock Available on a paid plan
Virus Diseases and HIV Infections
Clinical research at Hospital Universitario Araba includes studies in infectious diseases focused on HIV. The work is aimed at assessing the antiviral activity of new treatment approaches and understanding how well they control infection in people who have not yet received therapy.
- Evaluating a new antiviral therapy for HIV-1
- Studying treatment effectiveness in newly diagnosed, treatment-naive participants
- Supporting the development of better options for viral disease management
This research reflects the site’s strength in infectious disease medicine and its role in testing promising approaches for HIV care.
Neoplasms and Breast Cancer
The site also contributes to oncology research, with studies following people with early-stage invasive breast cancer. These trials are designed to track long-term outcomes and better understand relapse patterns after treatment.
- Observing the long-term course of early breast cancer
- Examining the timing and location of first relapse
- Improving knowledge of treatment outcomes in oncology
This line of research helps clarify how breast cancer behaves over time and supports more informed follow-up care for patients.
Nutritional and Metabolic Diseases and Type 1 Diabetes
Research in metabolic disease at Hospital Universitario Araba includes studies in type 1 diabetes mellitus. The main goal is to test whether a new therapy can help preserve the body’s own insulin production in children, adolescents, and young adults with recent diagnosis.
- Testing a new approach for preserving endogenous insulin secretion
- Studying treatment benefit in newly diagnosed type 1 diabetes
- Advancing care aimed at slowing disease progression
This research area combines endocrinology and metabolic medicine to explore ways of improving long-term diabetes management.
Female Urogenital Diseases and Pregnancy Complications and Menopause-Related Sleep Disturbances
The clinical trial portfolio also includes women’s health research focused on sleep disturbances associated with menopause. These studies are exploring whether a new treatment can ease symptoms and improve sleep quality in affected women.
- Assessing relief of menopause-related sleep problems
- Evaluating treatment impact on sleep quality and symptoms
- Supporting better options for women’s health care
This work highlights interest in improving everyday well-being through research on menopause and related quality-of-life concerns.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 19 therapeutic areas and 15 of 111 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 98 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 22 by active trials.
lock +21 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +11 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital Universitario Araba
lock Showing 1 of 52 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A 52-week randomized, double-blind, placebo-controlled, multi-center Phase 2b study with a 52-week blinded extension and an optional open-label extension—assessing the safety and efficacy of frexalimab, a CD40L-antagonist monoclonal antibody, for the preservation of pancreatic β-cell function in adults and adolescents with newly diagnosed type 1 diabetes on insulin therapy | Sanofi-Aventis Recherche & Developpement | Phase II | Not Recruiting | Feb 2024 | — |
IMP list
lock Showing 1 of 111 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Doxorubicin Hydrochloride | 5 | Unknown | 2018-01-10 | 2026-07-10 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.